Lipigon Pharmaceuticals Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • IPO

  • Latest Deal Amount
  • $6.59M

  • Investors
  • 4

Lipigon Pharmaceuticals General Information

Description

Lipigon Pharmaceuticals AB develops medicines for diseases caused by disorders of the body's handling of fats. It focuses on orphan drugs for unusual diseases where there is no adequate treatment.

Contact Information

Website
www.lipigon.se
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Tvistevägen 48 C
  • 907 36 Umeaa
  • Sweden
+46 070-578
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • Tvistevägen 48 C
  • 907 36 Umeaa
  • Sweden
+46 070-578

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lipigon Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. IPO 01-Mar-2021 $6.59M Completed Generating Revenue
6. Accelerator/Incubator Completed Generating Revenue
5. Later Stage VC 30-Jun-2020 Completed Generating Revenue
4. Later Stage VC 11-Feb-2019 Completed Generating Revenue
3. Later Stage VC 31-Dec-2017 Completed Generating Revenue
2. Later Stage VC 20-Dec-2016 $163K $163K Completed Generating Revenue
1. University Spin-Out 01-Jan-2010 Completed Startup
To view Lipigon Pharmaceuticals’s complete valuation and funding history, request access »

Lipigon Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary 13,144 $25.27 $25.27 1x $25.27 2.46%
Ordinary 21,202 $7.62 $7.62 1x $7.62 3.98%
To view Lipigon Pharmaceuticals’s complete cap table history, request access »

Lipigon Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lipigon Pharmaceuticals Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Almi Invest Venture Capital Minority
Fort Knox Family Office Minority
Umeå University University
Umeå Biotech Incubator Accelerator/Incubator Minority
To view Lipigon Pharmaceuticals’s complete investors history, request access »

Lipigon Pharmaceuticals Investments (3)

Lipigon Pharmaceuticals’s most recent deal was a PIPE with Larkberget for . The deal was made on 16-Sep-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Larkberget 16-Sep-2020 PIPE Private Equity
Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) 23-Mar-2020 Corporate Asset Purchase Buildings and Property
Larkberget 24-Oct-2019 PIPE Private Equity
To view Lipigon Pharmaceuticals’s complete investments history, request access »

Lipigon Pharmaceuticals ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Lipigon Pharmaceuticals’s complete esg history, request access »

Lipigon Pharmaceuticals FAQs

  • When was Lipigon Pharmaceuticals founded?

    Lipigon Pharmaceuticals was founded in 2010.

  • Where is Lipigon Pharmaceuticals headquartered?

    Lipigon Pharmaceuticals is headquartered in Umeaa, Sweden.

  • What is the size of Lipigon Pharmaceuticals?

    Lipigon Pharmaceuticals has 5 total employees.

  • What industry is Lipigon Pharmaceuticals in?

    Lipigon Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Lipigon Pharmaceuticals a private or public company?

    Lipigon Pharmaceuticals is a Private company.

  • What is the current valuation of Lipigon Pharmaceuticals?

    The current valuation of Lipigon Pharmaceuticals is .

  • What is Lipigon Pharmaceuticals’s current revenue?

    The current revenue for Lipigon Pharmaceuticals is .

  • How much funding has Lipigon Pharmaceuticals raised over time?

    Lipigon Pharmaceuticals has raised $10.1M.

  • Who are Lipigon Pharmaceuticals’s investors?

    Almi Invest, Fort Knox, Umeå University, and Umeå Biotech Incubator have invested in Lipigon Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process